[The incidence of serum anti-HBc and anti-HBs and tissue HBcAg in patients with HBsAg-negative hepatopathy].
D000914:Antibodies, Viral / Q000302:isolation & purification*; D002769:Cholelithiasis / Q000150:complications; D006505:Hepatitis / Q000276:immunology; D006509:Hepatitis B / Q000276:immunology; D006510:Hepatitis B Antibodies / Q000302:isolation & purification*; D006512:Hepatitis B Core Antigens / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006519:Hepatitis, Alcoholic / Q000276:immunology; D006801:Humans; D008103:Liver Cirrhosis / Q000276:immunology; D008107:Liver Diseases / Q000276:immunology*; D019966:Substance-Related Disorders / Q000150:complications
D000914:Antibodies, Viral; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens
L'incidenza di anti-HBc ed anti-HBs sierici e di HBcAg tissutale in pazienti con epatopatia HBsAG negativa.